Where does Mediplus Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Mediplus Ltd ranks #36,437 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Mediplus Ltd hold?

Mediplus Ltd holds 7 US utility patents granted between 2016 and 2024, spanning 8 technology areas.

What is Mediplus Ltd's Innovation Score?

Mediplus Ltd has an Innovation Score of 42.8 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Mediplus Ltd focus on?

Mediplus Ltd's top technology area is H04N (Pictorial Communication, e.g. Television) with 4 patents, ranking #2,514 of 5,951 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Mediplus Ltd's patent grant rate increasing or decreasing?

Mediplus Ltd's recent grant velocity is +33% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Mediplus Ltd's patents?

Mediplus Ltd's patents average 9.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Mediplus Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Mediplus Ltd

USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04N (Pictorial Communication, e.g. Television).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Mediplus ranks #36,437 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.

#36,437
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.8/100): 9.4
avg claims per patent: +33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R36437 · Foreign Corporation #36,437 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #36,437/49,997
PHOTO-FINISH Medgenics Medical…
CPC-NARROW H04N · 8 areas
INNOV-PAR 42.8/100
CLAIMS-PAR 9.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Medgenics Medical Israel Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Mediplus’s 42.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (17%) Velocity 20.0 pts (47%) Breadth 10.0 pts (23%) Claim depth 5.7 pts (13%)

Qualcomm Incorporated · highest

85
Mediplus · this assignee

43
3D Lighting… · lowest

7

What this shows Mediplus's Innovation Score is 42.8/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Mediplus?

Each dot is one of Mediplus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mediplus’s own 9.4 claims/patent is at or below the 15.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Mediplus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Mediplus's grants concentrate

Mediplus Ltd is a focused PatentsView assignee: 8 CPC subclasses with 57.1% of grants classified under H04N (Pictorial Communication, e.g. Television). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2016. By volume, Mediplus sits between Medgenics Medical Israel Ltd. and Menlo Microsystems, Inc..

Mediplus's three-year grant acceleration

Mediplus Ltd shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Medgenics Medical…

7
Medipines

7
Media Cart Holdin…

7
Mediaport Enterta…

7
Medlmmune

7
Meiragtx UK II

7
Melchor Gabilondo

7
Menlo Microsystems

7
Mediplus ◀

7

What this shows Mediplus holds 7 patents at rank #36,490, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Mediplus

By rank, the assignees closest to #36,490 in granted patent volume.

Leaders in H04N (Pictorial Communication)

Other assignees with the most granted patents in Mediplus's primary technology class.

Mediplus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Mediplus Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	14.3%
2017	1	14.3%
2019	1	14.3%
2022	2	28.6%
2024	2	28.6%

Which technologies does Mediplus Ltd patent most?

H04N - Pictorial Communication, e.g. Television 4

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

G06F - Electric Digital Data Processing 3

A61B - DIAGNOSIS; SURGERY; Identification 3

G11B - Information Storage Based ON Relative Movement Between Record Carrier AND Transducer 2

G09G - Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

G06T - Image Data Processing OR Generation, IN General 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Mediplus Ltd's patent record in context - here's where to go next.

Mediplus Ltd's lead technology class is H04N (Pictorial Communication, e.g. Television), 57.1% of its portfolio - see every assignee active in that class. Explore H04N
Ranked #36,437 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Mediplus Ltd against Medgenics Medical Israel Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.